The Frequency of Screening and SBT Technique Trial: The FAST Trial
1 other identifier
interventional
760
2 countries
17
Brief Summary
Background: The sickest patients who are admitted to an intensive care unit (ICU) often require assistance with their breathing. When patients start to get better, they gradually do more of the breathing and the machine does less-this is called weaning. Although ventilator use saves lives, the longer it is used, the more complications can occur. Clinicians aim to wean patients from ventilators in a timely and safe manner. In most ICUs, patients are screened (looked at) once per day to see if they are ready to undergo a weaning test (using a variety of techniques) to see if the breathing tube can be removed. Screening more than once per day may allow more weaning tests to be conducted. Knowing the best way to do a weaning test is important because some methods may better determine who can have the breathing tube removed safely. At present, we don't know the best way to help our sickest patients to wean from ventilators. Patients: Adults in North American ICUs who are on ventilators for at least 24 hours and who can take breaths on their own. Interventions: Patients in our study will receive one type of screening and one type of weaning test at random. In the 'once daily' screening groups, clinicians will screen patients each morning. In the 'two or more times daily screening' groups, patients will be screened in the morning, afternoon, and whenever else clinicians wish to screen. When screening criteria are met, patients will undergo one of two weaning tests with low ventilator support or no support. Outcomes: The main outcome of this study will be the time for patients to be successfully removed from the ventilator. Relevance: For patients, this study will clarify the best way to remove them from ventilators in a timely and safe manner. For clinicians and our health care systems, this study holds promise to improve how critically ill patients are weaned from breathing machines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Typical duration for not_applicable
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2016
CompletedFirst Posted
Study publicly available on registry
November 21, 2016
CompletedStudy Start
First participant enrolled
January 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedDecember 5, 2018
December 1, 2018
3.1 years
November 17, 2016
December 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to successful extubation
time from randomization to successful extubation
3-4 years
Secondary Outcomes (10)
ICU mortality
3-4 years
Hospital and 90 day mortality
3-4 years
Time to first passing an SBT
3-4 years
Total duration of mechanical ventilation (invasive and noninvasive),
3-4 years
ICU length of stay
3-4 years
- +5 more secondary outcomes
Study Arms (4)
Once daily screening + PS SBTs
ACTIVE COMPARATORIn this arm, RTs will screen patients between approximately 06:00 - 08:00 hrs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hrs of the scheduled screening period. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only PS\> 0 and =\< 8 cm H2O with PEEP\> 0 and =\< 5 cm H2O.
At least twice daily screening + PS SBTs
EXPERIMENTALIn this arm patients will be screened at a minimum between approximately 06:00 - 08:00 hours and 13:00 - 15:00 hs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hrs of the scheduled screening period. Additional screening trials in the 'at least twice daily' screening arm will be permitted at the discretion of the clinical team \[RTs and physicians\]. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only PS\>0 and =\< 8 cm H2O with PEEP\>0 and =\< 5 cm H2O.
Once daily screening + T-piece SBTs
ACTIVE COMPARATORIn this arm + PS SBT' arm, RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hrs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hrs of the scheduled screening period. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only T-piece (off the ventilator).
At least twice daily screening + T-piece SBTs
ACTIVE COMPARATORIn this arm, RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hours daily. If a screening period is missed inadvertently In the 'at least twice daily + PS SBT' screening arm patients will be screened at a minimum between approximately 06:00 - 08:00 hrs and 13:00 - 15:00 hrs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hours of the scheduled screening period. Additional screening trials in the 'at least twice daily' screening arm will be permitted at the discretion of the clinical team (RTs and physicians). Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only T-piece (off the ventilator).
Interventions
RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hours daily. To pass the 'readiness to wean screen' and undergo an SBT, specific criteria must be met.
In the 'at least twice daily' screening arm patients will be screened at a minimum between approximately 6:00-8:00 hours and 13:00-15:00 hours daily. To pass the 'readiness to wean screen' and undergo an SBT, specific criteria must be met.
Patients are assigned a SBT technique. All SBTs for these patients must be conducted on PS \>0 and =\< 8 cm H2O with PEEP\>0 and =\< 5 cm H2O
Patients are assigned a SBT technique. All SBTs for these patients must be conducted with T-piece (off the ventilator)
Eligibility Criteria
You may qualify if:
- Receiving invasive mechanical ventilation for \> or = 24 hours.
- Capable of initiating spontaneous breaths or triggering the ventilator to give a breath on ventilator modes commonly used in the ICU.
- Fractional concentration of inspired oxygen (FiO2) \< or = 70%.
- Positive End-Expiratory pressure (PEEP) \< or = 12 cm H2O.
You may not qualify if:
- Brain death or expected brain death.
- Evidence of myocardial ischemia in the 24 hour period before enrollment. Except if current trend in troponin is downward AND it has been \> or = 24 hours since last troponin peak or the patient has undergone a revascularization procedure and attending physician has no concerns regarding ongoing ischemia.
- Received continuous invasive mechanical ventilation for \> or = 2 weeks.
- Tracheostomy in situ at the time of screening.
- Receiving a sedative infusion(s) for seizures or alcohol withdrawal.
- Require escalating doses of sedative agents.
- Receiving neuromuscular blockers or who have known quadriplegia, paraplegia or 4 limb weakness or paralysis preventing active mobilization.
- Moribund (e.g., at imminent risk for death) or who have limitations of treatment.
- Profound neurologic deficits (e.g., post cardiac or respiratory arrest, large intracranial stroke or bleed) or Glasgow Coma Scale (GCS) \< or = 6.
- Use of ventilator modes that automate SBT conduct.
- Currently enrolled in a confounding study that includes a weaning protocol.
- Previous enrollment in this trial.
- Previous SBT or are already on T-piece, or CPAP alone (without PS), or PS \< or equal 8 cm H2O regardless of PEEP, or other 'SBT equivalent' settings immediately before randomization.
- Previous extubation \[planned, unplanned (e.g. self, accidental)\] during the same ICU admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (17)
Longbeach Memorial Hospital
Long Beach, California, 90806, United States
Keck Hospital of USC
Los Angeles, California, 90033, United States
Tufts Medical Center
Boston, Massachusetts, 02111, United States
University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
Temple University Hospital
Philadelphia, Pennsylvania, 19140, United States
Royal Alexandra Hospital
Edmonton, Alberta, T5H3V9, Canada
St. Paul's Hospital
Vancouver, British Columbia, Canada
Hamilton Health Sciences Hamilton General Hospital
Hamilton, Ontario, L8L2X2, Canada
Juravinski Hospital Cancer Centre
Hamilton, Ontario, Canada
St. Joseph's Hospital
Hamilton, Ontario, Canada
Niagara Health - St. Catharines
Niagara, Ontario, L2S 0A9, Canada
Ottawa General Hospital
Ottawa, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
St. Joseph's Health Centre
Toronto, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Universite de Sherbooke
Sherbrooke, Quebec, Canada
Ciusss McQ
Trois-Rivières, Quebec, G9A5C5, Canada
Related Publications (1)
Burns KEA, Wong J, Rizvi L, Lafreniere-Roula M, Thorpe K, Devlin JW, Cook DJ, Seely A, Dodek PM, Tanios M, Piraino T, Gouskos A, Kiedrowski KC, Kay P, Mitchell S, Merner GW, Mayette M, D'Aragon F, Lamontagne F, Rochwerg B, Turgeon A, Sia YT, Charbonney E, Aslanian P, Criner GJ, Hyzy RC, Beitler JR, Kassis EB, Kutsogiannis DJ, Meade MO, Liebler J, Iyer-Kumar S, Tsang J, Cirone R, Shanholtz C, Hill NS; Canadian Critical Care Trials Group. Frequency of Screening and Spontaneous Breathing Trial Techniques: A Randomized Clinical Trial. JAMA. 2024 Dec 3;332(21):1808-1821. doi: 10.1001/jama.2024.20631.
PMID: 39382222DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Burns, MD, FRCPC
St. Michael's Hospital (Toronto, Canada)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2016
First Posted
November 21, 2016
Study Start
January 18, 2018
Primary Completion
March 1, 2021
Study Completion
March 1, 2021
Last Updated
December 5, 2018
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share